Longitudinal cytological follow-up of patients with a Papanicolaou test interpretation of "atypical squamous cells of undetermined significance" that was followed by a negative reflex test for high-risk human papillomavirus types

International Journal of Gynecological Pathology

Volumn 27, Issue 1, 2008, Pages 108-112

  Rodriguez, Rosemarie ^a,b   Fadare, Oluwole ^a,c  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b San Antonio Uniformed Services Health Education Consortium   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Atypical squamous cells of undetermined significance; Bethesda 2001; Cervix; Consensus management guidelines; Human papillomavirus; Low grade squamous intraepithelial lesion

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CYTOLOGY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PATIENT CARE; PRIORITY JOURNAL; SQUAMOUS CELL; SQUAMOUS CELL CARCINOMA; SQUAMOUS INTRAEPITHELIAL LESION; UTERINE CERVIX DISEASE; VIRUS DETECTION; WART VIRUS; LONGITUDINAL STUDY; PAPILLOMA VIRUS; PATHOLOGY; PRACTICE GUIDELINE; PRECANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; FOLLOW-UP STUDIES; GUIDELINES AS TOPIC; HUMANS; LONGITUDINAL STUDIES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 39349105262     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/pgp.0b013e31804216b8     Document Type: Article

References (18)

1. Davey DD, Neal MH, Wilbur DC, et al. Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med 2004;128:1224-9.
2. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses: developed and approved at the National Cancer Institute workshop in Bethesda, MD, December 12-13, 1988. Diagn Cytopathol 1989;5:331-4.
3. Schiffman M, Adrianza ME. ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants. Acta Cytol 2000;44:726-42.
4. Solomon D, Schiffman M, Tarone R, ALTS Study group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-9.
5. ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. J Natl Cancer Inst 2003;188:1383-92.
6. Solomon D, Castle PE. Findings from ALTS: impact on cervical cytology screening, triage, and patient management. Pathol Case Rev 2005;10:128-37.
7. ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188:1393-400.
8. Schiffman M, Solomon D. Findings to date from the ASCUS-LSIL Triage Study (ALTS). Arch Pathol Lab Med 2003;127:946-9.
9. Wright TC Jr, Cox JT, Massad LS, et al. ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities. JAMA 2002;287:2120-9.
10. Stoler MH. New Bethesda terminology and evidence-based management guidelines for cervical cytology findings. JAMA 2002;287:2140-1.
11. Wright TC Jr, Cox JT, Massad LS, et al. 2001 ASCCP-sponsored Consensus Conference. 2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities. J Low Genit Tract Dis 2002;6:127-43.
12. Solomon D, Davey D, Kurman R, et al, Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
13. Lorincz A. Hybrid capture method of detection of human papillomavirus DNA in clinical specimens. Papillomavirus Rep 1996;7:1-5.
14. Lorincz A, Anthony J. Advances in HPV detection by Hybrid Capture. Papillomavirus Rep 2001;12:145-54.
15. Lorincz AT. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. J Obstet Gynaecol Res 1996;22:629-36.
16. Lorincz AT, Richart RM. Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs. Arch Pathol Lab Med 2003;127:959-68.
17. Chhieng DC, Chen J, Connolly K, et al. High-risk HPV DNA detection rate in patients with atypical squamous cells and its relationship to the atypical squamous cell: squamous intraepithelial lesion ratio. Acta Cytol 2006;50:291-4.
18. Stany MP, Bidus MA, Reed EJ, et al. The prevalence of HR-HPV DNA in ASC-US Pap smears: a military population study. Gynecol Oncol 2006;101:82-5.